SK Biopharmaceuticals. (326030.KQ) Q1 2026 Earnings

6FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
235.93
727.46
1,218.99
1,710.53

Details

Expected EPS
437.998400928
Actual EPS
1710.526956336
Surprise EPS
1,272.53
Surprise Percent
+290.53%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 1710.526956336 per share for Q1 2026.

0 Comments

Share your thoughts